The synapse is the primary locus underlying the acquisition and retention of memory. For example, in the marine mollusk, Aplysia, behavioral training that leads to sensitization and associative learning promotes a correlated facilitation of synaptic connections between specific neuron pairs (Castellucci et al., 1970; Hawkins et al., 1983; Kandel et al., 1986) . Training that promotes nonassociative behavioral habituation causes a homosynaptic depression of synaptic connections (Castellucci et al., 1970; Kandel et al., 1986) . Presynaptic changes that bring about synaptic plasticity can arise at the level of ion channels (Kandel and Schwartz, 1982; Gerschenfeld et al., 1986; Belardetti et al., 1987; Brezina et al., 1987; Brezina, 1988; Lipscombe et al., 1989; Man-Son-Hing et al., 1989) or secretory machinery (Llinas et al., 1985; Man-Son-Hing et al., 1989; Dale and Kandel, 1990; Hackett et al., 1990) . The regulation of ion channels alters the calcium influx during the action potential, while the regulation of secretory machinery controls the secretory response to elevated internal calcium. In cell culture experiments using identified neurons of Helisoma, our studies have demonstrated that the addition of a tetrapeptide, Phe-Met-Arg-Phe-NH, (FMRFamide), which is endogenous to the nervous system of Helisoma (Bulloch et al., 1988; Richmond et al., 1991) causes a presynaptic inhibition of synaptic transmission (Man-Son-Hing et al., 1989) . This presynaptic inhibition is brought about by at least two actions: FMRFamide reduces the presynaptic calcium current to reduce the calcium influx during the action potential and simultaneously reduces the secretory response to calcium (Man-Son-Hing et al., 1989) .
There are many subcellular signals that could mediate the actions of FMRFamide on secretory machinery in Helisoma. Man-Son-Hing and Haydon (1990) have shown that FMRFamide acts through a PTX-sensitive G-protein to reduce the presynaptic calcium current and that the activated a-subunit of the G-protein G,, has similar actions to FMRFamide's on the calcium current. Studies in non-neural cells have suggested that G-proteins also regulate secretory apparatus. In mast cells, for example, dialysis with GTPyS under conditions of low internal calcium stimulates rapid exocytosis (Femandez et al., 1984) . The role of G-proteins in regulating neurotransmitter release through actions on secretory apparatus has not been determined. Ngsee et al. (1990) have demonstrated, however, that multiple types of G-proteins, including PTX-sensitive G-proteins, are associated with small synaptic vesicles of the marine ray Dis-The goal of this study was to document quantitatively the action of FMRFamide on secretory apparatus and to determine whether this effect is mediated by a PTX-sensitive G-protein.
We have used a cell culture system of giant synaptic terminals to test for the involvement of G-proteins in regulating secretory apparatus. Identified neurons of Helisoma form chemical synapses between adjacent somata under conditions that prevent neurite extension (Haydon, 1988) . The spherical somata permit direct experimental access to presynaptic and postsynaptic elements of chemical synapses and, thus, the ability to microinject pharmacological agents that perturb G-protein activity. Using this system, we demonstrate that FMRFamide acts through a PTX-sensitive G-protein to reduce the secretory response to internal calcium.
Some of these data have appeared in preliminary form (Haydon et al., 1990; Man-Son-Hing and Haydon, 1990 ).
Materials and Methods
Cell culture. All experiments were performed on laboratory-reared adult specimens of the albino pond snail Helisoma trivolvis. Buccal ganglia were isolated according to previous techniques (Wong et al., 198 1; Haydon et al., 1985) and incubated in 0.2% trypsin (type III) in defined medium [Dm; 50% Liebowitz-15 (L-15) with salts for Helisoma] for 30 min at room temperature. Leibowitz-15 was purchased as a special order (82-5154EE) from GIBCO (Grand Island, NY) that was free of salts and glutamine. At the time of use, L-15 was diluted to 50% strength, and salts for Helisoma (in mM: NaCl, 40; CaCl,, 4.1; KCl, 1.7; MgCl,, 1.5; HEPES, 10; pH 7.3 with NaOH), L-glutamine (0.3 mg/ml), and gentamicin (50 &ml) were added. After incubation in trypsin, ganglia were pinned to a silicon rubber-based chamber for neuron isolation.
An electrolytically sharpened microknife was used to cut the connective sheath that covers the ganglia. The cut was made adjacent to the visually identified neuron to be isolated. Buccal neurons 5 (B5) and 19 (B 19) were removed from their ganglionic environment using suction from a fire-polished macropipette (about 100 pm tip diameter) and transferred to Falcon 1008 plastic Petri dishes for culture. Neurons were cultured in 50 ~1 of 10% freshly collected hemolymph in Dm. Neurons do not adhere to the culture substratum in the presence of hemolymph. In this environment, neurites never extend and somata maintain a spherical geometry (Haydon, 1988; Haydon and Zoran, 199 1) .
Neuronal somata of B5 and B 19 were plated adjacent to one another and made to contact in 10% hemolymph in Dm. Once contact was made, cells irreversibly adhered to one another for the duration of the culture period. After 1 d of culture, pairs of somata were transferred to fresh 10% hemolymph, and by the second day had formed unidirectional cholinergic chemical synapses. On days 2 or 3, synaptic partners were transferred to poly-L-lysine coated Petri dishes so that they became immobilized for immediate electrophysiological examination. Synaptic partners are devoid of neurites and make contact directly between somata (Haydon, 1988) . Neurons were viewed using a Nikon Diaphot inverted microscope. All electrophysiological recordings were made in Dm.
Presynaptic intracellular recordings. Presynaptic neuron B5 was penetrated with glass fiber-fill microelectrodes that were characteristically filled with (in mM) 50 KCl, 5 EGTA, 2.56 CaCl,, and 10 K+ HEPES (pH 7.3). When microinjection was required, the tip of the electrode was broken by touching the electrode against a glass coverslip before the onset of recording. To test the pressure injection capacity of each electrode (2 pm tip diameter), a pressure pulse (30 psi, 50 msec) was applied to the electrode while viewing the ejection of the electrode filling solution in a droplet of glycerol. Intracellular records were stored on VHS tape using a Unitrade PCM recorder and later transferred to chart paper using a Gould 220 pen recorder. In some experiments, the presynaptic neuron was voltage clamped using a single electrode switched voltage-clamp circuit (Dagan 8800).
Postsynaptic voltage clamp. Postsynaptic neuron B19 was voltage clamped in the whole-cell configuration using a patch pipette with a DC resistance of 14 MQ, which was connected to an Axopatch 1C patchclamp amplifier (Axon Instruments, Burlingame, CA). The pipette solution of postsynaptic neuron (B19) contained (in mM) 50 KCl, 5 MgCl,, 5 EGTA, and 5 K+ HEPES at pH 7.3. The release ofacetylcholine (ACh) from neuron B5 activates chloride channels that normally cause an inhibitory postsynaptic potential in B19. By using 50 mM KC1 in the postsynaptic patch solution and holding B 19 at -80 mV, synaptic currents became inward currents that were readily detected above the noise level of postsynaptic recordings (Zucker and Haydon, 1988; Man-SonHing et al., 1989) .
Presynaptic calcium clamp. Our previous calcium-clamp experiments utilized the photosensitive calcium cage nitr-5 (Man- Son-Hing et al., 1989) . However, due to toxicity associated with long-term use of nitr-5 (P. G. Haydon, unpublished observations) we used the calcium cage DM-nitrophen (Kaplan and Ellis-Davies, 1988 ) in the present study. In preliminary experiments, we determined that DM-nitrophen has no detectable toxic effects for at least 1 hr following injection into the presynaptic cytosol. The calcium-clamp solution for microinjection contained (in mM) 75 DM-nitrophen, 22 CaCl,, 1 fluo-3, and 10 HEPES, pH 7.3.
After microinjection of the DM-nitrophen/Ca solution, the synchronized release of neurotransmitter was promoted using a 15 msec flash of UV light (UGl 1 excitation filter, Omega Optical), which was delivered from a 75 W mercury vapor lamp through an epifluorescence 40 x oil immersion objective (Nikon) of a Nikon Diaphot inverted microscope. Delaney and Zucker (1990) and Zoran et al. (199 1) have previously shown that flash photolysis of calcium-loaded DM-nitrophen promotes calcium-dependent transmitter release. Fluo-3 was included in the injection solution so that DM-nitrophen injection could be visually monitored and to confirm qualitatively that photolysis elevated internal calcium. Fluo-3 was excited at 485 nm (22 nm band pass), and the emission signal was collected using a 5 10 nm long-pass filter. A dichroic mirror that efficiently reflected light at UV and 485 nm but transmits fluorescence emission at > 500 nm (Omega Optical) was used in these experiments since it permits both UV photolysis and the excitation of fluo-3 (Kao et al., 1989) .
Quanta1 analysis of synaptic currents. To determine whether action potential+voked synaptic transmission is quanta1 in nature, we compared the magnitudes of spontaneous and evoked IPSCs. Transmitter release was reduced by elevating the concentration of Mg2+ in the bathing medium from the standard 1.5 mM until failures in synaptic transmission were detected. Elevated Mg2+ concentration varied between preparations but was in the range of 5-20 mM. The magnitude of spontaneous miniature inhibitory postsynaptic currents (MIPSCs) was unaffected by alterations in extracellular Mg*+ concentration. Assuming quanta1 release of neurotransmitter, the elevation of extracellular Mg2+ will reduce the number of quanta released by action potentials until evoked IPSCs are largely due to one quantum. Since MIPSCs arise from only one neuron under these cell culture conditions, we asked whether evoked IPSCs could be fit by a Gaussian distribution with a mean and standard deviation measured from spontaneous MIPSCs in the same preparation. In some cases, multiple Gaussian distributions were fit to the evoked IPSC data using means and standard deviations corresponding to onefold, twofold, and threefold the values obtained for the unitary MIPSCs. Analysis of events was performed using ~CLAMP software (Axon Instruments). The heights of Gaussian distributions for evoked IPSCs were estimated using Poisson statistics.
Presynaptic injections. To test for G-protein involvement in mediating the actions ofFMRFamide on secretory machinery, guanine nucleotides were microinjected into the presynaptic soma. GTP and GTPrS (2 mM) were injected into the presynaptic cell in a standard internal saline consisting of (in mM) 50 KCl, 2.56 CaCl,, 5 EGTA, and 10 K+ HEPES (pH 7.3). Characteristically, nucleotides were injected using three to five 50 msec pulses of 30 psi pressure that was controlled by a Narashige IM-200 pressure injection system. The final nucleotide concentrations were estimated in separate experiments by measuring the fluorescent emission intensity of the dye fluorescein that had been injected into neuron B5. We estimate that following microinjection, nucleotides were diluted to a final concentration of 13 PM.
To begin to identify the class of G-protein that mediates FMRFamide's actions, the A-protomer of pertussis toxin (PTX) was injected into neuron B5 for between 20 min and 4 hr before testing the effect of FMRFamide.
Similar observations were obtained independent of the duration of PTX incubation in neurons. PTX (0.2 &pl) was stored in 40 mM dithiothreitol (DTT) in the standard internal solution. Immediately before microinjection, PTX was mixed with an equal volume of 40 mM NAD+ and 10 mM ATP in internal saline to yield a solution containing 0.1 pa/w1 PTX, 20 mM DTT, 20 mM NAD', and 5 mM ATP. We standardly &inject nicotinamide adenine dinuclectide (NAD') and ATP with PTX to oermit effective ADP-ribosvlation of G-proteins.
Measurement of MIPSC frequency. MIPS& were counted in 1 min time bins to obtain measurements of MIPSC frequency. Action potentials in the presynaptic cell were prevented by injecting constant, hyperpolarizing current into B5 to bring the membrane potential of this cell just below threshold for spikes. Characteristically, a 5 min control period of secretory activity was monitored before FMRFamide ( lO-9 M to 10ms M) was added to the bathing medium. Neurons were exposed to FMRFamide for 6 min and were washed with 30 ml of Dm (recording chamber volume = 1 ml) and allowed 6 min for recovery. The average MIPSC frequency was determined during minutes 5 and 6 of FMRFamide exposure or of recovery for comparison to the average frequency during the 5 min pretest period. When a dose-response curve was constructed, synapses were excluded from analysis ifthe frequency of MIPSCs did not return to within +25% of the pretest value.
Estimation of intracellular free calcium. To determine whether
FMRFamide affected the internal free calcium level of the presynaptic neuron in the absence of the calcium cage DM-nitrophen, cells were loaded with the fluorescent calcium indicator fura- (Grynkiewicz et al., 1985) . .The soma-soma synapse was incubated for 1.5 hr in 5 PM fura-acetoxymethyl ester (fura 2/AM) at room temperature followed by incubation for a period of >2 hr in Dm for deesterification of the indicator. Fura-2-loaded neurons B5 and B19 were transferred from their culture dishes onto polylysine-coated glass coverslips attached to the underside of a Falcon 1008 Petri dish, in which a 1 cm diameter hole had been drilled in the base.
Fura-was excited with UV light alternating between 340 and 380 nm. Fluorescent emission (5 10 nm) was recorded with a photomultiplier tube, and the emission intensities at excitation wavelengths of 340 (10 nm band pass) and 380 nm (13 nm band pass) were recorded using the UMANS system (Chester M. Regen, Urbana, IL). Quantitation of estimated internal free calcium was performed using the ratiometric method according to Cohan et al. (1987) .
Calcium current. Whole-cell recordings of macroscopic calcium currents in presynaptic membrane were made according to techniques described by Haydon and Man-Son-Hing (1988) and Man-Son-Hing et al. (1989) . Patch pipettes (l-2 MrJ DC resistance) were filled with an internal solution that contained (in mM) 35 CsCl, 5 MgCl,, 5 EGTA, 5 HEPES, and 1 GTP (Tris salt) (pH 7.3 with CsOH). The internal solution usually contained 5 mM ATP (Na+ salt); similar results were obtained with or without ATP. Spherical somata were bathed in an external saline that contained (in mM) 0 NaCl, 4.1 CaCl,, 1.5 MgCl,, 1.7 KCl, 30 tetraethylammonium (TEA) Br, 10 4-aminopyridine, 10 HEPES, and 30 sucrose (pH 7.3 with TEA OH). These solutions effectively block Na+ and K+ currents. Neurons were depolarized from a holding potential of -60 mV to depolarized command potentials of -50 to +50 mV. Unfortunately, it is not possible to monitor transmitter release and the presynaptic calcium current since the conditions required for ideal study of the calcium current block synaptic transmission.
When neuron B5 is plated in nonadhesive culture and retains a spherical geometry, it loses its low-voltage-activated calcium current but selectively maintains a high-voltage-activated (HVA) calcium current.
The somatic HVA calcium current is electrophysiologically and pharmacologically similar to the calcium current of growth cones of neuron B5 (Haydon, 1988) . Chemicals. GTP was obtained from Sigma (St. Louis, MO), GTPrS from Boehringer Mannheim Biochemicals (Indianapolis, IN), fura-2/AM from Molecular Probes (Eugene, OR), pertussis toxin (A-protomer) from List Biological Labs (Campbell GA), FMRFamide from Bachem (Philadelphia, PA), and DM-nitrophen from Calbiochem (La Jolla, CA).
All data are presented as means + SEM unless otherwise stated. Statistical tests of significance were performed using the Student's t test.
Results
Calcium-clamped, synchronized synaptic transmission
Our previous studies of secretory machinery were performed by analyzing the frequency of asynchronous MIPSCs under calcium clamp. Our assumption in such experiments was that the modulation of MIPSC frequency was indicative of a modulation of the amount of transmitter released under synchronous release conditions during the action potential. Delaney and Zucker (1990) demonstrated that the calcium cage DM-nitrophen (Kaplan and Ellis-Davies, 1988) can be effectively used to promote the synchronized release of transmitter from the squid giant synapse. We have injected DM-nitrophen into the presynaptic soma of Helisoma giant synapses and demonstrated that this calcium cage can also promote synchronized transmitter release at this synapse.
DM-nitrophen was microinjected, together with fluo-3 into the presynaptic cell body. Fluo-3 was used to demonstrate that DM-nitrophen was successfully injected into the synapse and that photolysis caused an increase in intracellular free Ca2+. No quantitative estimates of free calcium levels were made with fluo-3. Flash photolysis (15 msec) reliably promoted the synchronized release of neurotransmitter from this synpase (Fig.  1A) . The amplitude of the flash-evoked IPSC was dependent on both the duration and intensity of UV photolysis. When UV flashes shorter than 15 msec duration were applied to preparations, the magnitude of the synchronized IPSCs was reduced. However, flash-to-flash variability in IPSC magnitude was considerably increased. With 15 msec duration UV flashes, the flash-evoked IPSC was characteristically much larger than the spike-evoked IPSC (Fig. lA,B , note the different calibration values). The time course of the flash-evoked synchronized IPSC was very similar to the IPSC evoked in response to an action potential (Fig. lc) .
Consecutive UV flashes promoted the release of neurotransmitter (Fig. 1D) . However, in general each successive IPSC had a smaller amplitude. The amount of rundown of flash-evoked synaptic transmission was variable between preparations. For this reason, we performed preliminary experiments to determine this variability. The decrease in flash-evoked IPSC amplitude from the first to the second flash was determined. In 11 preparations, the magnitude of the second IPSC decreased to 0.78 + 0.55 (mean f SD) of the first. This considerable variability is likely due to true biological intersynaptic variability and to different amounts of loading with DM-nitrophen. Having obtained this estimate of the variability between synapses, preparations were excluded from analysis in subsequent experiments if the amplitude of the second flash-evoked IPSC fell outside of the range 0.23-1.33 (one SD around the mean) or if flash photolysis failed to evoke an IPSC in the washout period. Action potential+voked IPSCs do not exhibit this rundown, which may represent the depletion of the readily releasable pool of transmitter under conditions of high transmitter output during flash photolysis. To test the effect of FMRFamide on synaptic transmission, pairs of UV flashes (2 min flash interval) were provided in three groups (period 1, pretest; period 2, test; and period 3, washout; examples of IPSCs obtained from control ( Fig. 2A ) and experimental (Fig. 2B) preparations. The average of two IPSCs during the pretest (1) and the average of two IPSCs during test (2) periods are superimposed. In the control preparation ( Fig. 2A) , the characteristic rundown of flash-evoked release can be seen.
Comparison to Figure 2B shows that the amplitude of the IPSCs in the experimental preparation in the presence of FMRFamide (Fig. 2B , trace 2) is smaller than the amplitude of IPSCs in the test period of the control preparation ( Fig. 2A, trace 2) . In 10m6 M FMRFamide, IPSCs had a normalized value of 0.28 f 0.07 (n = 7) compared to 0.69 f 0.19 (n = 6) in parallel control preparations (p < 0.05, one-tailed t test). Figure 2C presents these data as a ratio of the values of the experimental to control preparations within each period. FMRFamide (1 Om6 M) reduced the ratio of IPSC amplitude from a value of 1.0 in the pretest period to 0.40 -+ 0.11 in the test period. Following washout of FMRFamide, there is little recovery in the IPSC amplitude, the ratio increasing to only 0.48 f 0.17. Since FMRFamide does not affect postsynaptic sensitivity to released neurotransmitter (Man-Son-Hing et al., 1989; Haydon, unpublished observations) , these data demonstrate that the pool of neurotransmitter released under conditions of a rapid elevation of calcium is modulated by the peptide FMRFamide.
Quanta1 release of neurotransmitter For studies of secretory machinery, it is preferable to use a stable index of synaptic function in which rundown is not present. One such index is provided by monitoring the spontaneous release of neurotransmitter. To determine whether action potentialevoked IPSC comprises the same event as spontaneously occurring MIPSCs, we compared the amplitudes and kinetic properties of these two types of neurotransmitter release. The amplitudes of spontaneous MIPSCs and spike-evoked IPSCs from four preparations were measured under conditions of elevated extracellular Mgz+, which reduces the quanta1 content of synaptic transmission. Extracellular Mg2+ was elevated so that the magnitude of evoked IPSCs was reduced and preparations exhibited failures in synaptic transmission. Figure 3A shows the amplitude distribution for spontaneously occurring MIPSCs in one preparation. The quanta1 size of MIPSCs was 23.5 -t 8.1 pA. A Gaussian distribution is superimposed on the raw data in Figure 3A . Action potentials were evoked presynaptically, and the amplitudes of IPSCs were measured; 200 action potentials evoked 113 IPSCs with 87 failures. Knowing the proportion of failures, we calculated the quanta1 content of synaptic transmission to be 0.8. Division of the mean amplitude of the evoked IPSC (16.8 PA) by the quanta1 size, q (23.5 PA), estimates the quanta1 content, m, to be 0.72. Knowing m, q, and the SD of q, we used Poisson statistics to estimate the frequency of failures, and incidence of one, two, and three quanta released by presynaptic action potentials. The sum of three Gaussian curves showing such predicted data is superimposed on the raw frequency distribution histogram of evoked IPSC amplitudes in Figure 3B . The predicted and observed distributions were not significantly different (x2, p > 0.1). The insets to arations studied. The mean unitary MIPSC size was 12.5 f 3.97 pA (n = 4; range, 5-24 PA). Taken together, these data indicate that action potentials cause the quanta1 release of neurotransmitter.
FMRFamide reduces the frequency of MIPSCs Dale and Kandel (1990) have shown that a change in the frequency of spontaneous EPSPs at cell-cultured Aplysia sensorymotor synapses is correlated with the modulation of secretory machinery. To monitor presynaptic secretory machinery, we recorded the frequency of spontaneous MIPSCs. Since there was considerable intersynaptic variability in the frequency of spontaneous MIPSCs, we have expressed MIPSC frequency as values normalized to the average frequency obtained during the initial 5 min pretest recording period from the same synapse. Bath application of FMRFamide (1O-6 M) reliably reduced the frequency of MIPSCs (n = 7). FMRFamide reduced the MIPSC frequency from a normalized pretest value of 1 .O to 0.7 1 + 0.12, a 29% reduction in MIPSC frequency (Fig. 4) . lation was found between initial MIPSC frequency and the extent of FMRFamide's modulation of MIPSC frequency. The inhibitory action of FMRFamide on MIPSC frequency was surprisingly slow. In a previous report (Man-Son-Hing et al., 1989) where nitr-5 was used to control internal calcium, we showed that FMRFamide acts on secretory machinery within seconds of application (see Fig. 2c of Man-Son-Hing et al., 1989) . In the present experiments, however, where resting calcium levels and MIPSC frequency were both relatively low, FMRFamide was present for minutes before an action on MIPSC frequency was reliably revealed (Fig. 4A ).
Previous calcium-clamp experiments (Man-Son-Hing et al., 1989; also Fig. 2 above) demonstrated that FMRFamide's inhibitory effect on MIPSC frequency is due to a direct effect on secretory apparatus, rather than on internal calcium levels. Using fura-to detect internal free Ca2+, we detected no change in internal free Ca2+ during FMRFamide application in the present experiments. The addition of FMRFamide for 5 min periods in concentrations ranging from 10m6 to 1O-4 M did not change the resting free calcium level in the presynaptic soma. The lack of effect of FMRFamide on resting calcium levels at these concentrations, which are up to 5 orders of magnitude greater than the concentration required for modulating MIPSC frequency (see below), supports our previous observation that 
Injection of guanine nucleotides
To begin to determine whether FMRFamide acts through a G-protein-mediated signal transduction pathway, a nonhydrolyzable analog ofGTP, GTPyS, was injected into the presynaptic soma while recording the frequency of MIPSCs. GTPyS injection (n = 4) reduced the frequency of MIPSCs over a period of 5 min following microinjection (Fig. 54) . The actions of GTP and GTPrS injection were quantified by calculating the mean MIPSC frequency during the fourth and fifth minutes following microinjection. GTPrS injection (n = 4) reduced the frequency of MIPSCs to a value 0.26 f 0.03 of the preinjection value, while GTP injection (n = 3) only reduced the rate to 0.64 f 0.12 (p < 0.002, two-tailed t test). This action of GTPyS is consistent with a G-protein-activated pathway exerting an inhibitory effect on MIPSC frequency.
PTX prevents FMRFamideS inhibitory efect on secretory machinery
To test more critically for a G-protein requirement for FMRFamide to act on secretory machinery, and to begin to identify the class of G-protein mediating this inhibitory effect, we injected the A-protomer of PTX into the presynaptic soma. Fifteen minutes after injection, the baseline frequency of MIPSCs was measured for a control 5 min period. The frequency of MIPSCs was not significantly different between PTX-injected (12.8 + 3.9 pA, mean f SD) and heat-inactivated PTX-injected cells (18.3 f 13.5 pA, mean f SD). Twenty minutes after injection, the effect of FMRFamide was determined. Following PTX injection, FMRFamide had a significantly attenuated inhibitory action on secretory machinery (Fig. 5C ). In PTX injected cells, FMRFamide (lo+ M) reduced the frequency of A PTX-sensitive G-protein mediates FMRFamide's modulatory actions on synaptic transmission Since we have demonstrated that a PTX-sensitive G-protein is involved in mediating FMRFamide's actions on secretory machinery (Fig. 5) as well as on ion channels (Man-Son-Hing et al., 199 l), we determined whether a similar class of G-protein mediates FMRFamide's actions on the modulation of action potential-evoked synaptic transmission. Presynaptic somata were preinjected with the A-protomer of PTX up to 4 hr prior to recording. Following PTX injection, FMRFamide (10-G M) had little modulatory effect on action potential-evoked synaptic transmission. FMRFamide reduced the evoked IPSC from a pretest value of 1.0 to 0.86 -t 0.09 (n = 5; Fig. 6A ), while in control preparations injected with heat-inactivated PTX, FMRFamide ( 1O-6 M) reduced synaptic transmission from 1 .O to 0.35 * 0.09 (n = 5; p < 0.002, two-tailed t test; Fig. 6B ). Thus, PTX-sensitive G-proteins are involved in mediating actions of FMRFamide on the presynaptic calcium current (ManSon-Hing et al., 1991), on secretory machinery (Fig. 5) and on action potentialevoked synaptic transmission (Fig. 6 ).
Dose-response curves for the actions of FMRFamide
To begin to quantify the contribution of the modulation of secretory machinery and calcium channels to the modulation of action potential+voked release of neurotransmitter, we constructed dose-response curves for each component. Somata of neuron B5 were voltage clamped in the whole-cell configuration and depolarized from a holding potential of -60 mV to a command potential (O-20 mV) to evoke the maximum magnitude of HVA calcium current in the cell (Haydon and Man-Son-Hing, 1988) . Addition of FMRFamide at concentrations of 3 x lo-' M, or greater, reversibly reduced the calcium current magnitude (Fig. 7) . This action is judged to be a reduction in a calcium current rather than an increase in potassium current, since (1) addition of Cd*+ reduces both the calcium current magnitude and the extent of FMRFamide's modulation of the calcium current, (2) FMRFamide does not change the positive reversal potential of the calcium current, and (3) FMRFamide causes the same relative reduction in calcium current magnitude at all command potentials (Man-Son-Hing et al., 1989) .
To determine quantitatively the action of FMRFamide on secretory machinery, MIPSC frequency was measured. FMRFamide reduced the frequency of MIPSCs at concentrations as low as 1O-9 M (Fig. 7) . Thus, FMRFamide can act on secretory machinery at a concentration 2 orders of magnitude lower than on the HVA calcium current.
Reduction in action potential-evoked IPSC magnitude We determined whether low doses of FMRFamide, which modulate MIPSC frequency but have no significant effect on calcium current magnitude, will modulate action potential+voked synaptic transmission. Single action potentials were evoked in the presynaptic cell at l-5 min intervals while recording the magnitude of the evoked IPSC. The IPSC magnitude is variable between preparations and may range from about 20 to 1000 pA. However, the extent of FMRFamide's modulation is consistent irrespective of IPSC size. Action potential+evoked IPSCs were reduced in ampiitude by i 9 ? 17% by additim of i&3=7 M FMRFamide (n = 7 in three preparations; Fig. 7 ). This modulation of spike-evoked release can be accounted for by the selective modulation of secretory machinery since lo-' M FMRFamide reduced MIPSC frequency by 27 + 3%. FMRFamide at 1 O-6 M reduced the action potential+evoked IPSC by 7 1 + 10% (n = 5). This reduction in evoked IPSC amplitude is likely a result of the combined modulation of secretory machinery and the calcium current since 1O-6 M FMRFamide reduced MIPSC frequency by 41 f 9% and reduced the calcium current by 13 * 2% of control values (Fig. 7) .
Discussion
The neuropeptide FMRFamide, which is endogenous to the nervous system of Helisoma (Murphy et al., 1985; Bulloch et al., 1988; Richmond et al., 199 l) , causes a presynaptic inhibition of ACh release from neuron B5 (Man-Son-Hing et al., 1989) . In addition to affecting action potential+voked synaptic transmission and the magnitude of a voltage-sensitive calcium current, FMRFamide also reduces MIPSC frequency. This reduction in MIPSC frequency is judged to be due to an action on secretory machinery since the calcium-sensitive fluorophore fura-did not detect a FMRFamide-induced change in free calcium even at a peptide concentration 5 orders of magnitude greater than the threshold concentration for affecting MIPSC frequency. While it is possible that a subplasma-membrane change in calcium concentration could go undetected in such experiments, additional evidence supports the modulation of secretory machinery per se. For example, FMRFamide reduces MIPSC frequency when the presynaptic soma is filled with an experimentally injected calcium chelator that becomes the dominant calcium buffer (Man-Son-Hing et al., 1989) . FMRFamide modulates MIPSC frequency at concentrations that do not affect calcium influx (Fig. 7) , and FMRFamide reduces the synchronized IPSC amplitude evoked by flash photolysis of DM-nitrophen (Fig. 2) . Taken together, this evidence demonstrates that FMRFamide modulates secretory machinery by reducing its responsiveness to internal Ca2+.
G-protein requirement for secretory machinery modulation
The injection of the nonhydrolyzable analog of GTP, GTP$S, significantly depressed the frequency of MIPSCs. Further, PTX attenuated the inhibitory action of lO-6 M FMRFamide on MIPSC frequency. Taken together, these data demonstrate the involvement of a PTX-sensitive G-protein in mediating FMRFamide's action on secretory machinery. Similarly, ManSon-Hing and Haydon (1990) demonstrated that a PTX-sensitive G-protein mediates the action of FMRFamide on the presynaptic calcium current of this same neuron. Whether the same or different G-proteins mediate these two actions of FMRFamide on calcium current and secretory machinery is unknown.
G-protein-dependent modulation of secretory machinery has been demonstrated in insulin-secreting cells. Addition of noradrenaline to isolated islets of Langerhans inhibits glucose-induced insulin secretion (Jones et al., 1987) . Using permeabilized islets in the presence of Ca*+/EGTA, Jones et al. (1987) also showed that Ca2+-stimulated secretion is reduced by noradrenaline. Using isolated, single insulin-secreting RINmSF cells, Ullrich and Wollheim (1988) demonstrated that this inhibitory step is blocked by preincubation with PTX, indicating a G-protein regulation of secretory machinery.
Studies in non-neural cells indicate that G-proteins may be involved in a late step controlling exocytosis (Gomperts, 1990) . The introduction of nonhydrolyzable analogs of GTP into a variety of cells can stimulate Ca 2+-independent secretion. Guanine nucleotide-dependent secretion can be triggered in adrenal medullary cells (Knight and Baker, 1985) adrenal chromaffin cells (Bittner et al., 1986) , neutrophils (Barrowman et al., 1986) parathyroid cells (Oetting et al., 1986) and mast cells (Femandez et al., 1984) . There is some crossover between guanine nucleotide-stimulated secretion and Caz+-dependent secretion since GDP&S inhibits guanosine 5'-(By-imido triphosphate (GMP-PNP)-dependent secretion and partially inhibits Ca*+-dependent secretion in chromaffin cells (Bittner et al., 1986) . The stimulatory effects of GTPyS and GMP-PNP have led to the suggestion that there is an as of yet unidentified G-protein, G,, which is involved in one of the later steps controlling exocytosis. There is no evidence to support the presence of G, in neural tissue. Ca2+ -dependent secretion from permeabilized nerve endings isolated from rat neurohypophysis does not require the presence of GTP (Cazalis et al., 1987) although GTP addition can enhance Ca*+-dependent secretion. GTPyS injection into squid giant presynaptic terminal reduces synaptic transmission (Hess and Augustine, 1990 ). This action is mediated at least in part through effects on presynaptic ion channels, and the G-protein modulation of secretory machinery is currently undefined (Hess and Augustine, 1990) . Injection of GTPrS into the secretory soma of neuron B5 caused a reduction in MIPSC frequency. An elevation of MIPSC frequency was not detected. Thus, in this nerve terminal we have no evidence to support the existence of a G,-like G-protein. We cannot discount the possibility that the inhibitory action of the PTXsensitive G-protein is overriding a stimulatory effect of a G, following GTPyS injection.
Vesicle mobilization
There are multiple mechanisms that may mediate the action of FMRFamide on secretory machinery. For example, FMRFamide might reduce the transmitter pool available for exocytosis. By injecting purified synapsin I, a vesicle-associated protein, and Ca*+/calmodulin-dependent protein kinase II into the squid giant synapse, Llinas et al. (1985) demonstrated that the state of phosphorylation of synapsin I can modulate the release of transmitter in response to a constant calcium influx. Injection of dephospho-synapsin I reduced transmitter release. Injection of Ca*+/calmodulin-dependent protein kinase II, which phosphorylates synapsin I, enhanced transmitter release. Using video-enhanced microscopy, McGuiness et al. (1989) demonstrated that dephospho-synapsin I inhibits organelle movement along extruded microtubules, while phosphorylation of synapsin I removed such inhibitory effects. Assuming that similar immobilizing actions could be exerted by actin, a synapsin-binding protein of nerve terminals, such results suggest that dephosphosynapsin I regulates the amount of transmitter released by crosslinking synaptic vesicles with cytoskeleton, reducing vesicle mobilization and the available pool of transmitter for release. It is unknown whether FMRFamide is acting through such a mechanism.
In Aplysia, FMRFamide's effects on "S" type K channels have been shown to act through a phospholipase and promote the release of arachidonic acid metabolites (Piomelli et al., 1987) . Piomelli et al. (1989) recently demonstrated that arachidonic acid and lipoxygenase-derived eicosanoids selectively inhibit Ca*+/calmodulin-dependent protein kinase II activity. Thus, the arachidonic acid-derived metabolites are good candidates for mediating the actions of FMRFamide on secretory machinery through the inhibition of Ca *+-calmodulin-dependent protein kinase II (Piomelli and Greengard, 1990) . Alternatively, FMRFamide may have similar effects through the activation of protein phosphatases (Ichinose et al., 1990 ).
In the experiments described herein, MIPSC frequency was not reduced until minutes had elapsed following addition of FMRFamide. This is in contrast to a previous report (Man-SonHing et al.,. 1989 ) where we demonstrated that MIPSC frequency is reduced within seconds of FMRFamide application. In those previous experiments, internal calcium was experimentally elevated using the photolabile calcium cage nitr-5, which promoted an accelerated frequency of MIPSCs. The kinetic distinction between FMRFamide's rate of action in these two sets of experiments could be related either to the different calcium levels or to different MIPSC frequencies. Perhaps there is a calcium-sensitive component to the signal transduction pathway, such as phospholipase A,, for the actions of FMRFamide. Alternatively, the cycling rate of synaptic vesicles may affect the kinetics of FMRFamide action. Based on the observations of Llinas et al. (1985) and McGuiness et al. (1989) in squid, FMRFamide may affect the ability of synaptic vesicles to be mobilized from a nonreleasable pool to the pool of vesicles docked at the plasma membrane that are available for release. If FMRFamide affects such a mobilization process, the kinetics of peptide action would be related to the frequency of exocytosis, since at higher MIPSC frequencies, vesicle depletion and mobilization would come into play more rapidly.
Ultrastructural evidence indicates that the transmitter pool immediately available for release is dynamic. In Aplysia, Bailey and Chen (1988) have investigated the ultrastructural modifications of sensory neuron terminals following periods of behavioral training that promote synaptic plasticity. Under training conditions that lead to short-term homosynaptic depression, the number of vesicles available for release (vesicles within 30 nm of the active zone) is markedly reduced while the total number of vesicles is unaffected. Thus, experimental evidence demonstrates that short-term perturbations can lead to alterations in the transmitter pool available for release, and leaves open the possibility that FMRFamide acts in such a manner.
The plasticity of synaptic transmission at sensory-motor synapses in Apfysia is regulated by changes in calcium influx (Blumenfeld et al., 1990) and by effects on secretory machinery (Dale and Kandel, 1990) . The neuromodulatory transmitter 5-HT facilitates synaptic transmission. Hochner et al. (1986) demonstrated that under conditions of homosynaptic depression, 5-HT has a facilitatory action on synaptic transmission through a process other than spike broadening and channel modulation and suggest that this may be due to a mobilization of vesicles from a storage pool to the available transmitter pool. Modeling studies of Gingrich and Byrne (1985) show that the mobilization of vesicles to the available transmitter pool can account for this result. FMRFamide reduces synaptic transmission at sensorymotor synapses (Piomelli et al., 1987) . In addition to the modulation of ion channels , FMRFamide prevents the 5-HT-induced activation of the second process of facilitation (Pierioni and Byrne, 1990) , which involves the modulation of secretory machinery.
In Helisoma, secretory machinery is affected by FMRFamide at concentrations lower than those required for actions on the calcium current. FMRFamide at 1 Om7 M, which has insignificant effects on the voltage-sensitive calcium current, does affect secretory machinery and causes a small reduction in synaptic transmission. Since there is a nonlinear relation between calcium current and neurotransmitter release (Augustine et al., 1985) we cannot discount the possibility that a small reduction in calcium current magnitude is contributing to the modulation of transmitter release. However, the reduction of transmitter release can be accounted for solely by the modulation of secretory machinery at lo-' M FMRFamide (Fig. 7A) . By contrast, at 1 O-6 M FMRFamide, both the modulation of calcium current and secretory machinery are required to account for the reduction of IPSC amplitude (Fig. 7A) . Our data at lo-' M FMRFamide are in support of a previous observation that demonstrated that synaptic modulation can arise due to the regulation of secretory machinery alone (Llinas et al., 1985) . This selective modulation of secretory machinery permits the regulation of synaptic output without affecting the presynaptic ion conductances and integrative properties of this neuron.
Modulators of synaptic transmission might act at the level of secretory apparatus in a variety of synapses. Dephospho-synapsin I injection decreases transmitter release in the squid giant synapse (Llinas et al., 1985) and reduces the quanta1 content (m) of synaptic transmission at goldfish Mauthner synapses (Hackett et al., 1990) . Phorbol esters (Malenka et al., 1987) and neurotransmitters (Dale and Kandel, 1990 ) that promote synaptic plasticity can concomitantly change the frequency of spontaneous miniature potentials. Adenosine and its analogs modulate miniature end plate potential frequency coincidently with evoked transmission at the neuromuscular junction (Silinsky, 1984; Singh et al., 1986) . Thus, the modulation of secretory machinery might be an important site that underlies synaptic plasticity in many synapses,
